RENEE D GALA Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for RENEE D GALA.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of RENEE D GALA. RENEE D GALA is Director in CORCEPT THERAPEUTICS INC ($CORT) and EVP & CFO in Jazz Pharmaceuticals plc ($JAZZ) and SVP, Chief Financial Officer in Theravance Biopharma, Inc. ($TBPH) and SVP-Finance in Theravance Biopharma, Inc. ($TBPH) and VP-Finance in Theravance Biopharma, Inc. ($TBPH) and Director in Gossamer Bio, Inc. ($GOSS).
Latest Insider Trading Transactions of RENEE D GALA
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, CORT, GOSS, JAZZ, TBPH
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 07 2021 | JAZZ | Jazz Pharmaceutica ... | GALA RENEE D | EVP & CFO | Payment of Exercise | F | 164.71 | 1,515 | 249,536 | 25,347 | 26.9 K to 25.3 K (-5.64 %) |
| Mar 01 2021 | JAZZ | Jazz Pharmaceutica ... | GALA RENEE D | EVP & CFO | Grant | A | 0.00 | 10,115 | 0 | 26,862 | 16.7 K to 26.9 K (+60.40 %) |
| Jun 18 2020 | GOSS | Gossamer Bio, Inc. | GALA RENEE D | Director | Option Exercise | A | 12.10 | 23,500 | 284,350 | 23,500 | |
| May 11 2020 | JAZZ | Jazz Pharmaceutica ... | GALA RENEE D | EVP & CFO | Option Exercise | A | 109.45 | 37,848 | 4,142,464 | 37,848 | |
| May 11 2020 | JAZZ | Jazz Pharmaceutica ... | GALA RENEE D | EVP & CFO | Option Exercise | A | 109.45 | 3,652 | 399,711 | 3,652 | |
| May 11 2020 | JAZZ | Jazz Pharmaceutica ... | GALA RENEE D | EVP & CFO | Grant | A | 0.00 | 16,600 | 0 | 16,600 | 0 to 16.6 K |
| Jun 11 2019 | GOSS | Gossamer Bio, Inc. | GALA RENEE D | Director | Option Exercise | A | 19.54 | 23,500 | 459,190 | 23,500 | |
| Nov 21 2018 | TBPH | Theravance Biophar ... | GALA RENEE D | SVP, Chief Financia ... | Payment of Exercise | F | 24.79 | 6,697 | 166,019 | 157,657 | 164.4 K to 157.7 K (-4.07 %) |
| Aug 22 2018 | TBPH | Theravance Biophar ... | GALA RENEE D | SVP, Chief Financia ... | Payment of Exercise | F | 26.95 | 6,695 | 180,430 | 164,354 | 171 K to 164.4 K (-3.91 %) |
| Aug 22 2018 | CORT | CORCEPT THERAPEUTI ... | GALA RENEE D | Director | Option Exercise | A | 14.08 | 25,000 | 352,000 | 25,000 | |
| Aug 16 2018 | TBPH | Theravance Biophar ... | GALA RENEE D | SVP, Chief Financia ... | Sell | S | 27.43 | 1,700 | 46,623 | 171,049 | 172.7 K to 171 K (-0.98 %) |
| Aug 16 2018 | TBPH | Theravance Biophar ... | GALA RENEE D | SVP, Chief Financia ... | Sell | S | 26.71 | 39,839 | 1,064,032 | 172,749 | 212.6 K to 172.7 K (-18.74 %) |
| Aug 16 2018 | TBPH | Theravance Biophar ... | GALA RENEE D | SVP, Chief Financia ... | Sell | S | 27.74 | 2,204 | 61,136 | 212,588 | 214.8 K to 212.6 K (-1.03 %) |
| May 22 2018 | TBPH | Theravance Biophar ... | GALA RENEE D | SVP, Chief Financia ... | Payment of Exercise | F | 24.31 | 21,230 | 516,101 | 214,792 | 236 K to 214.8 K (-8.99 %) |
| May 22 2018 | TBPH | Theravance Biophar ... | GALA RENEE D | SVP, Chief Financia ... | Sell | S | 24.29 | 10,000 | 242,877 | 236,022 | 246 K to 236 K (-4.06 %) |
| May 16 2018 | TBPH | Theravance Biophar ... | GALA RENEE D | SVP, Chief Financia ... | Grant | A | 0.00 | 33,750 | 0 | 246,022 | 212.3 K to 246 K (+15.90 %) |
| Mar 07 2018 | CORT | CORCEPT THERAPEUTI ... | GALA RENEE D | Director | Buy | P | 15.53 | 9,000 | 139,802 | 10,000 | 1,000 to 10 K (+900.00 %) |
| Mar 07 2018 | CORT | CORCEPT THERAPEUTI ... | GALA RENEE D | Director | Buy | P | 15.30 | 1,000 | 15,300 | 1,000 | 0 to 1,000 |
| Feb 22 2018 | TBPH | Theravance Biophar ... | GALA RENEE D | SVP, Chief Financia ... | Payment of Exercise | F | 29.09 | 5,387 | 156,708 | 211,407 | 216.8 K to 211.4 K (-2.48 %) |
| Nov 22 2017 | TBPH | Theravance Biophar ... | GALA RENEE D | SVP, Chief Financia ... | Payment of Exercise | F | 28.58 | 6,753 | 193,001 | 207,794 | 214.5 K to 207.8 K (-3.15 %) |
| Aug 22 2017 | TBPH | Theravance Biophar ... | GALA RENEE D | SVP, Chief Financia ... | Payment of Exercise | F | 27.40 | 6,752 | 185,005 | 214,547 | 221.3 K to 214.5 K (-3.05 %) |
| May 26 2017 | CORT | CORCEPT THERAPEUTI ... | GALA RENEE D | Director | Option Exercise | A | 12.13 | 30,000 | 363,900 | 30,000 | |
| May 23 2017 | TBPH | Theravance Biophar ... | GALA RENEE D | SVP, Chief Financia ... | Payment of Exercise | F | 36.83 | 6,753 | 248,713 | 221,299 | 228.1 K to 221.3 K (-2.96 %) |
| Feb 22 2017 | TBPH | Theravance Biophar ... | GALA RENEE D | SVP, Chief Financia ... | Payment of Exercise | F | 33.78 | 10,211 | 344,928 | 226,350 | 236.6 K to 226.4 K (-4.32 %) |
| Feb 08 2017 | TBPH | Theravance Biophar ... | GALA RENEE D | SVP, Chief Financia ... | Grant | A | 0.00 | 9,000 | 0 | 236,561 | 227.6 K to 236.6 K (+3.95 %) |
| Nov 22 2016 | TBPH | Theravance Biophar ... | GALA RENEE D | SVP, Chief Financia ... | Payment of Exercise | F | 31.96 | 4,628 | 147,911 | 227,561 | 232.2 K to 227.6 K (-1.99 %) |
| Aug 23 2016 | TBPH | Theravance Biophar ... | GALA RENEE D | SVP, Chief Financia ... | Payment of Exercise | F | 27.89 | 4,306 | 120,094 | 232,189 | 236.5 K to 232.2 K (-1.82 %) |
| Jun 28 2016 | CORT | CORCEPT THERAPEUTI ... | GALA RENEE D | Director | Option Exercise | A | 5.11 | 70,000 | 357,700 | 70,000 | |
| Jun 28 2016 | CORT | CORCEPT THERAPEUTI ... | GALA RENEE D | Director | Option Exercise | A | 5.11 | 70,000 | 357,700 | 70,000 | |
| May 24 2016 | TBPH | Theravance Biophar ... | GALA RENEE D | SVP, Chief Financia ... | Payment of Exercise | F | 20.55 | 3,333 | 68,493 | 236,495 | 239.8 K to 236.5 K (-1.39 %) |
| Mar 17 2016 | TBPH | Theravance Biophar ... | GALA RENEE D | SVP, Chief Financia ... | Grant | A | 0.00 | 90,000 | 0 | 238,125 | 148.1 K to 238.1 K (+60.76 %) |
| Feb 23 2016 | TBPH | Theravance Biophar ... | GALA RENEE D | SVP, Chief Financia ... | Payment of Exercise | F | 15.65 | 13,052 | 204,264 | 148,125 | 161.2 K to 148.1 K (-8.10 %) |
| Aug 17 2015 | TBPH | Theravance Biophar ... | GALA RENEE D | SVP, Chief Financia ... | Buy | P | 12.16 | 5,000 | 60,800 | 161,177 | 156.2 K to 161.2 K (+3.20 %) |
| Aug 17 2015 | TBPH | Theravance Biophar ... | GALA RENEE D | SVP, Chief Financia ... | Buy | P | 12.19 | 5,000 | 60,950 | 154,279 | 149.3 K to 154.3 K (+3.35 %) |
| Feb 09 2015 | TBPH | Theravance Biophar ... | GALA RENEE D | SVP, Chief Financia ... | Grant | A | 0.00 | 135,000 | 0 | 149,279 | 14.3 K to 149.3 K (+945.44 %) |
| Aug 22 2014 | TBPH | Theravance Biophar ... | GALA RENEE D | SVP-Finance | Payment of Exercise | F | 26.98 | 158 | 4,263 | 14,279 | 14.4 K to 14.3 K (-1.09 %) |
| Jul 23 2014 | TBPH | Theravance Biophar ... | GALA RENEE D | SVP-Finance | Option Exercise | A | 32.13 | 85,000 | 2,731,050 | 85,000 | |
| Jun 05 2014 | TBPH | Theravance Biophar ... | GALA RENEE D | VP-Finance | Option Exercise | A | 23.51 | 85,000 | 1,998,350 | 85,000 |
Page: 1